102 related articles for article (PubMed ID: 9562451)
1. Therapy for good risk germ cell tumors.
McCaffrey JA; Bajorin DF
Semin Oncol; 1998 Apr; 25(2):186-93. PubMed ID: 9562451
[TBL] [Abstract][Full Text] [Related]
2. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.
Hinton S; Catalano PJ; Einhorn LH; Nichols CR; David Crawford E; Vogelzang N; Trump D; Loehrer PJ
Cancer; 2003 Apr; 97(8):1869-75. PubMed ID: 12673712
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for good-risk germ-cell tumors.
Ryan CJ; Bajorin DF
Semin Urol Oncol; 2002 Nov; 20(4):244-50. PubMed ID: 12489057
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy of disseminated germ cell tumors].
Kimura G; Akimoto M
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1873-90. PubMed ID: 9797810
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of metastatic testicular carcinoma according to prognosis; new development].
de Wit R; Stoter G
Ned Tijdschr Geneeskd; 2001 Jun; 145(25):1194-9. PubMed ID: 11447874
[TBL] [Abstract][Full Text] [Related]
8. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
[TBL] [Abstract][Full Text] [Related]
9. Management of good risk germ-cell tumours.
Troost MM; Sternberg CN; de Wit R
BJU Int; 2009 Nov; 104(9 Pt B):1387-91. PubMed ID: 19840018
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for advanced germ cell tumors.
Kondagunta GV; Motzer RJ
J Clin Oncol; 2006 Dec; 24(35):5493-502. PubMed ID: 17158534
[TBL] [Abstract][Full Text] [Related]
11. [Treatment decision in advanced testicular germ cell tumors].
Salazar Soler R; Montesinos Muñoz J; Maroto Rey P; Villavicencio Mavrich H
Arch Esp Urol; 2000; 53(6):522-33. PubMed ID: 11002521
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
[TBL] [Abstract][Full Text] [Related]
13. Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors.
Kondagunta GV; Bacik J; Bajorin D; Dobrzynski D; Sheinfeld J; Motzer RJ; Bosl GJ
J Clin Oncol; 2005 Dec; 23(36):9290-4. PubMed ID: 16361627
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of disseminated germ cell tumors.
Nichols CR
Semin Urol Oncol; 2001 Aug; 19(3):157-64. PubMed ID: 11561982
[TBL] [Abstract][Full Text] [Related]
16. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of advanced testicular cancer and toxicity of chemotherapy].
Kawakita M; Matsuda T; Terachi T; Yoshida O
Hinyokika Kiyo; 1999 Nov; 45(11):783-6. PubMed ID: 10637744
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of carboplatin-based chemotherapy for pediatric germ cell tumors.
Stern JW; Bunin N
Med Pediatr Oncol; 2002 Sep; 39(3):163-7. PubMed ID: 12210444
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of germ cell tumors at the threshold of the third millennium].
Géczi L; Biron P; Droz JP
Orv Hetil; 2001 Aug; 142(31):1673-9. PubMed ID: 11556261
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of TIP (paclitaxel, ifosfamide, cisplatin) into first-line therapy for intermediate to poor risk testicular germ cell tumors with unfavorable marker decline after initial two cycles chemotherapy: a report of three cases.
Ishioka J; Kageyama Y; Ichiyanagi N; Fukuda H; Higashi Y
Int J Urol; 2007 May; 14(5):455-7. PubMed ID: 17511735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
